HealthQuill
Intensive diet and lifestyle changes may forestall a cognitive decline in Alzheimer’s disease and make progress for patients during early stages, a study finds.
Health Research

Parkinson’s Disease cases to hit 25 million worldwide by 2050

HQ Team March 10, 2025: A recent study published in The BMJ forecasts a significant rise in Parkinson’s disease cases globally, with projections.

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Health Research

Aspirin shows promise in preventing cancer metastasis

HQ Team March 10, 2025: University of Cambridge scientists have uncovered the mechanism behind how aspirin could reduce the spread of certain cancers.

Read More
IntraBio Inc, a biotechnology company focused on rare and neurodegenerative diseases, got the US regulator’s nod for a drug to treat a certain type of Niemann-Pick disease in adults and pediatric patients weighing about 15 kilograms.
Health

Primary care clinics can help detect 10% of cancers caused by genes

HQ Team March 10, 2025: Patient screening in primary care settings can detect up to 10% of cancers caused by genes. Easily available.

Read More
obesity
Health Research

Over half of adults and a third of children projected to be overweight by 2050

HQ Team March 8, 2025: A study published in The Lancet by the Global Burden of Disease Study BMI Collaborators reveals alarming statistics.

Read More
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Health

Haemorrhage and preeclampsia lead in pregnancy-related deaths: WHO study

HQ Team March 8, 2025: A study by the World Health Organization (WHO), Global and Regional Causes of Maternal Deaths 2009–2020, has identified severe.

Read More
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the US-based company.
Drugs Pharma

Johnson & Johnson ends late-stage trial of depression drug aticaprant

HQ Team March 7, 2025: Johnson & Johnson is discontinuing the Phase 3 VENTURA clinical trial of its experimental depression drug aticaprant after.

Read More
pollution
Climate

Half of world’s CO2 emissions linked to 36 fossil fuel companies: Report

HQ Times March 7, 2025: A report by Carbon Majors has Coal India listed second among 36 fossil fuel companies responsible for half.

Read More
Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latter’s technology to discover tissue-targeting molecules.
Drugs Medical Pharma

Novo Nordisk to pay US-based Gensaic $354 million upfront in licensing deal

HQ Team March 5, 2025: Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latter’s.

Read More
US scientists have blocked a protein that kills a variety of cancer cells in an experiment on mice, pointing to a new potential target for cancer treatment, according to the National Institutes of Health.
Drugs Health Research

US scientists block proteins that aid cancer cells’ group strategy to survive

HQ Team March 5, 2025: US scientists have blocked a protein that kills a variety of cancer cells in an experiment on mice,.

Read More
In ancient Greece, King Midas wished for the golden touch, believing that unlimited wealth would bring him ultimate happiness. However, his dream quickly turned into a nightmare when his food—and even his beloved daughter—turned to gold.  Midas became trapped by his irrational desire, blinded by the allure of wealth without considering its consequences.
Health Opinion Research

Curbing the King Midas’ golden touch in you during modern times

By Aparna S March 4, 2025: In ancient Greece, King Midas wished for the golden touch, believing that unlimited wealth would bring him.

Read More